CAINI, PATRIZIO
 Distribuzione geografica
Continente #
NA - Nord America 2.611
EU - Europa 1.330
AS - Asia 253
AF - Africa 2
OC - Oceania 1
Totale 4.197
Nazione #
US - Stati Uniti d'America 2.602
PL - Polonia 336
SE - Svezia 277
IE - Irlanda 269
IT - Italia 132
HK - Hong Kong 106
CN - Cina 86
DE - Germania 77
UA - Ucraina 63
FI - Finlandia 57
BE - Belgio 39
GB - Regno Unito 38
TR - Turchia 35
AT - Austria 18
JO - Giordania 11
VN - Vietnam 9
CA - Canada 8
CH - Svizzera 8
FR - Francia 5
SG - Singapore 5
NL - Olanda 4
RU - Federazione Russa 4
NO - Norvegia 2
SC - Seychelles 2
AU - Australia 1
CZ - Repubblica Ceca 1
IN - India 1
MX - Messico 1
Totale 4.197
Città #
Fairfield 394
Warsaw 336
Chandler 280
Dublin 269
Ashburn 221
Woodbridge 201
Seattle 178
Wilmington 165
Cambridge 156
Houston 129
Ann Arbor 115
Jacksonville 102
Beijing 70
Princeton 61
Buffalo 56
Hong Kong 54
Altamura 50
Lawrence 45
Boardman 44
Boston 43
Brussels 39
Izmir 35
Bremen 34
Medford 29
Florence 24
San Diego 19
Washington 15
Vienna 14
Falls Church 13
Norwalk 13
Shanghai 12
New York 11
Bern 8
Hillsboro 6
Salerno 6
Toronto 6
Auburn Hills 5
Frankfurt Am Main 5
Singapore 5
Andover 4
London 4
Caserta 3
Old Bridge 3
Verona 3
Bastia umbra 2
Dong Ket 2
Grevenbroich 2
Laurel 2
Los Angeles 2
Meppel 2
Munich 2
Oslo 2
Padova 2
Paris 2
Phoenix 2
Redmond 2
Rome 2
Aachen 1
Bergamo 1
Bologna 1
Brisbane 1
Brno 1
Catanzaro 1
Civitanova Marche 1
Dearborn 1
Fuzhou 1
Genoa 1
Guangzhou 1
Hanoi 1
Hefei 1
Incisa 1
Kunming 1
Leawood 1
Milan 1
Montréal 1
Mérida 1
Naaldwijk 1
Napanee 1
New Bedfont 1
Pune 1
Redwood City 1
San Mateo 1
Stanford 1
Tappahannock 1
Worcester 1
Totale 3.339
Nome #
Role of MicroRNA Profile Modifications in Hepatitis C Virus-Related Mixed Cryoglobulinemia 218
Notch4 and mhc class II polymorphisms are associated with hcv-related benign and malignant lymphoproliferative diseases 156
The effects of phosphate on the contraction of single skeletal myofibrils 131
Interferon-free therapy in hepatitis C virus mixed cryoglobulinaemia: a prospective, controlled, clinical and quality of life analysis 121
Modifications of plasma platelet-activating factor (PAF)- acetylhydrolase/PAF system activity in patients with chronic hepatitis C virus infection 115
Host genetic determinants in HCV-related mixed cryoglobulinemia 112
Association Between Persistent Lymphatic Infection By Hepatitis C Virus After Antiviral Treatment And Mixed Cryoglobulinemia 106
Host genetic determinants in HCV-related mixed cryoglobulinemia 98
Safety and efficacy of rituximab in patients with hepatitis C virus-related mixed cryoglobulinemia and severe liver disease 97
Can BAFF promoter polymorphism be a predisposing condition for HCV-related mixed cryoglobulinemia? 95
Effect of antiviral treatment in patients with chronic HCV infection and t(14;18) translocation 92
Effect of chronic hepatitis C virus infection on inflammatory lipid mediators 87
T(14;18) translocation in chronic hepatitis C virus infection 86
Hepatitis C virus core protein expression in human B-cell lines does not significantly modify main proliferative and apoptosis pathways 83
CD81 modulation by immobilized monoclonal antibodies is able to promote B-cell proliferation and c-myc expression 83
Involvement of PI3K in HCV-related lymphoproliferative disorders 82
Elevated plasma levels of urotensin II do not correlate with systemic haemodynamics in patients with cirrhosis. 82
Improvement in liver cirrhosis after treatment of HCV-related mixed cryoglobulinemia with rituximab 81
HCV core protein expression in human B cell lines does not significantly modify proliferative and apoptosis pathways. 80
CD81 Modulation by Immobilized Monoclonal Antibodies is Able to Promote B-cell proliferation and C-MYC expression 80
HCV-related mixed cryoglobulinemia and BAFF promoter polymorphism 79
Analysis of HCV persistence in patients with sustained virological response 79
COMBINED PRESENCE OF HCVRNA SEQUENCES AND T(14;18) (q32;q21) TRANSLOCATION IN PBMC FROM PATIENTS WITH CHRONIC HCV INFECTION. 78
Hepatitis C virus core protein enhances B lymphocyte proliferation 75
CD81 MODULATION BY IMMOBILIZED MONOCLONAL ANTIBODIES IS ABLE TO PROMOTE B-CELL PROLIFERATION AND C-MYC EXPRESSION 75
HCV core protein expression in human B cell lines does not significantly modify proliferative and apoptosis pathways 71
Extrahepatic manifestations of Hepatitis C Virus infection: A general overview and guidelines for a clinical approach 71
Regression of t(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection 70
Triple antiviral therapy in hepatitis C virus infection with or without mixed cryoglobulinaemia: A prospective, controlled pilot study. 70
Combined presence of HCVRNA sequences and t(14;18) (q32;q21) translocation in PBMC from patients with chronic HCV infection 69
Alterazioni del sistema pPAF-AH/PAF in pazienti con infezione cronica da HCV 69
Host genetic determinants in HCV-related mixed cryoglobulinemia 68
HCV core protein expression in human B cell lines does not significantly modify proliferative and apoptosis pathways 66
Regression of T(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection. 65
VALUE OF IL28B GENOTYPING IN PATIENTS WITH HCV-RELATED MIXED CRYOGLOBULINEMIA: RESULTS OF A LARGE, PROSPECTIVE STUDY 65
Regression of t(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection. 65
Crioglobulinemia e linfoma in corso di infezione da HCV 60
HCV core protein induces B lymphocytes proliferation increasing DNP63 expression 59
Behaviour of sustained responders to anti-HCV treatment: may HCV infection be eradicated? 53
Bcl-2 rearranged B cell clones in chronic HCV infection: a possible factor negatively influencing the virological response to treatment 50
null 48
Regression of T(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection. 46
Prevalence of bcl-2 rearrangement in hepatitis C virus-related mixed cryoglobulinemia with or without B-cell lymphomas. 45
Reply: HCV infection and psychopathological disorders 44
Different metabolic fingerprints between HCV and HBV patients: a possible interference of the two major hepatitis viruses in basal metabolism pathways. 44
Genetic determinants in Hepatitis C Virus-associated mixed cryoglobulinemia: role of polymorphic variants of BAFF promoter and Fc-gamma receptors 42
Il polimorfismo dell'interleuchina 28B come predittore di risposta in pazienti con crioglobulinemia mista HCV-correlata 41
IL28B polymorphism as predictor of response to anti-HCV terapy in HCV-related mixed cryoglobulinemia syndrome 39
Efficacia del trattamento antivirale nell’indurre la regressione di cloni B cellulari alberganti la traslocazione t(14;18) nell’infezione cronica da virus C dell’epatite (HCV). 37
Plasma PAF-AH biological activity decreases in patients with HCV chronic infection 37
Eventi Oncomolecolari nella Crioglobulinemia Mista 37
Safety and effectiveness of boceprevir triple therapy in patients with mixed cryoglobulinemia 34
Prevalence of bcl-2 recombination in hepatitis C virus-related mixed cryoglobulinemia with or without complicating B-cell lymphoma. 33
La cimentazione della proteina CD81 con ligandi specifici promuove la proliferazione di cellule B e l’espressione della proteina c-myc 32
Long-term outcome of HCV-related mixed cryoglobulinemia in patients achieving sustained viral sustained viral response (SVR) after antiviral therapy 32
Regression of T(14;18) rearing B-cell clones following antiviral therapy in chronic HCV infection 31
Prevalenza della ricombinazione Bcl-2 in pazienti con crioglobulinemia mista HCV correlata complicata o meno da linfoma.. 30
Modifications of Plasma PAF-AH activity in Patients with Chronic HCV infection 28
Presence of BCL-2 rearranged B-cell clones in chronic HCV infection may negatively influence virological response to treatment 26
Prevalence of bcl-2 recombination in hepatitis C virus-related mixed cryoglobulinemia with or without complicating B-cell lymphoma. 25
Infezione delle cellule linfatiche da parte del virus C dell’epatite: fatti e controversie 22
Prevalence of bcl-2 recombination in hepatitis C virus related mixed cryoglobulinemia with or without complicating B-cell lymphoma 15
Totale 4.210
Categoria #
all - tutte 10.938
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.938


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019438 0 0 0 0 0 0 0 0 13 83 194 148
2019/2020926 78 65 20 81 97 105 94 108 96 92 77 13
2020/2021528 54 32 32 72 16 64 17 37 52 75 45 32
2021/2022431 4 49 15 15 15 17 16 30 21 9 90 150
2022/20231.202 100 152 75 108 114 226 175 69 126 12 28 17
2023/2024347 20 56 68 30 27 66 7 65 8 0 0 0
Totale 4.210